Skip to main content
Wed, Mar 18, 2026
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
GeneralUnited States3 sourcesNeutral

Ulrich Wendt joins UK biotech Alchemab Therapeutics as Chief Business Officer to expand biopharma partnerships

Alchemab Therapeutics has appointed Ulrich Wendt, PhD MBA, as Chief Business Officer (CBO) to expand partnerships with

MA
my account
via Norfolk Daily News - Corroborated by 2 others
ShareRead original

Read the full article at Norfolk Daily News →

Ulrich Wendt joins UK biotech Alchemab Therapeutics as Chief Business Officer to expand biopharma partnerships

Source Verification

Corroboration Score: 3

This story was independently reported by 3 sources. Click any source to read the original article.

Norfolk Daily News
Norfolk Daily News
NewsDataUS
Businesswire
Businesswire
NewsDataUK
BW
Business Wire
GNews

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
Gas Prices Keep Climbing as Seasonal Changes Add to Oil Price Pressure
Next
Democrats like Markwayne Mullin but that doesn’t mean they’ll vote for him for DHS secretary

Related Articles

გლობალურმა ავტოინდუსტრიამ ტრამპის ტარიფების გამო მინიმუმ 35 მილიარდი დოლარი დაკარგაGeneral
გლობალურმა ავტოინდუსტრიამ ტრამპის ტარიფების გამო მინიმუმ 35 მილიარდი დოლარი დაკარგა
Unknown-3h ago-1 sources
Uganda Athletics set for elective assembly on March 28General
Uganda Athletics set for elective assembly on March 28
Gabriel Esiku-3h ago-1 sources
General
Rosatom's Tugansk MPP intends to occupy 84% of zirconium concentrate market in Russia, expects exports to Asia
Unknown-4h ago-1 sources